Puma Biotechnology appoints director
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Puma Biotechnology Inc. appointed Michael Miller as a director with a term expiring at the 2018 annual meeting of stockholders.
Miller has served as the executive vice president of U.S. commercial at Jazz Pharmaceuticals PLC since May 2017.
